Share on StockTwits

Greatbatch (NYSE:GB) hit a new 52-week high on Thursday , Stock Ratings Network reports. The company traded as high as $48.49 and last traded at $48.34, with a volume of 27,352 shares traded. The stock had previously closed at $47.24.

Several analysts have recently commented on the stock. Analysts at Sterne Agee initiated coverage on shares of Greatbatch in a research note on Tuesday. They set a “buy” rating and a $53.00 price target on the stock. Separately, analysts at KeyCorp initiated coverage on shares of Greatbatch in a research note on Wednesday, April 9th. They set a “buy” rating and a $55.00 price target on the stock. Finally, analysts at Zacks downgraded shares of Greatbatch from an “outperform” rating to a “neutral” rating in a research note on Tuesday, April 8th. They now have a $47.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $48.50.

The stock’s 50-day moving average is $46.36 and its 200-day moving average is $43.9. The company has a market cap of $1.201 billion and a price-to-earnings ratio of 26.63.

Greatbatch (NYSE:GB) last announced its earnings results on Wednesday, April 30th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.04. The company had revenue of $174.00 million for the quarter, compared to the consensus estimate of $158.48 million. On average, analysts predict that Greatbatch will post $2.33 earnings per share for the current fiscal year.

Greatbatch, Inc (NYSE:GB) is developer and manufacturer of components for implantable medical devices (IMDs) and Electrochem batteries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.